fashion -WSS

fashion

author：focus 2025-10-01 13:58:48 - browse：75489

Illustration of three connected puzzle pieces, with a woman standing near the missing/empty puzzle piece space. -- first opinion coverage from STAT — Adobe

Women have always been underrepresented in medical research. A new study reveals that not much has changed, especially when it comes to tests of cardiovascular devices.

In a paper published in JAMA Internal Medicine on Monday, researchers found that the percentage of women represented in high-risk medical device trials did not increase from 2010 to 2020. Women generally made up just 33% of participants when the team reviewed 195 trials published from 2016 to 2022. The percentages varied between devices: Women made up 46% of participants in orthopedic trials, but 29% in cardiovascular studies.

The issue isn’t new. The government has made some strides in correcting earlier missteps, like the Food and Drug Administration telling researchers in 1977 to exclude women of reproductive potential from early clinical trials. But stakeholders think agencies like the FDA could do more to incentivize the enrollment of women.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： What the cancer research community can learn from the Covid response

focus

knowledge

WSS

A former Republican legislative candidate has been charged for his role in the US Capitol riot

White House drug shortage group privately met with industry

Reframing the conversation around gain

Microsoft strikes partnership with Duke Health to advance health AI

Reframing the conversation around gain

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

knowledge

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Florida babysitter arrested over hot car death, authorities say

Supreme Court strikes down use of affirmative action

Humana, CVS hope to turn members into patients at clinics

Trump demands the U.S. pay no more for drugs than other countries … again

What the cancer research community can learn from the Covid response

As demand for Covid shots wanes, Moderna seeks its next success

TytoCare raises $49 million to build out AI

The high cost of giving birth even with insurance

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

hotspot

Listen: BridgeBio's big week & Lilly's Alzheimer's data

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

New chart reveals military’s vast involvement in Operation Warp Speed

EMA weighs against approval for Mirati's lung cancer drug

2 US Navy sailors arrested for allegedly spying for China

Reframing the conversation around gain

focus

focus

knowledge

hotspot